Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin
AUTOR(ES)
Mello, Amanda Gabryelle Nunes Cardoso, Vieira, Michelle Valéria Dias Ferreira, Sena, Luann Wendel Pereira de, Paixão, Thiago Portal da, Pinto, Ana Carla Godinho, Grisólia, Daniella Paternostro de Araújo, Silva, Margareth Tavares, Vieira, José Luiz Fernandes
FONTE
Rev. Inst. Med. trop. S. Paulo
DATA DE PUBLICAÇÃO
25/10/2018
RESUMO
ABSTRACT In the last two years, a substantial increase in the number of malaria vivax cases has occurred in the Brazilian Amazon basin. The adequate exposure of hypnozoites to primaquine is a matter of interest as these dormant forms are responsible for the maintenance or even the increase of malaria burden in endemic areas. The aim of this study was to estimate the levels of primaquine and carboxyprimaquine in whole blood samples of patients with P. vivax treated with chloroquine and an abbreviated regimen of primaquine (0.5 mg/kg/d for 7 days), with adequate clinical and parasitological outcomes after 180 days of follow-up. A total of 40 male patients met the criteria for inclusion in the study. Primaquine and carboxyprimaquine were measured by high-performance liquid chromatography. The levels of primaquine in whole blood samples ranged from 40-238 ng/mL, 42-196 ng/mL and 42-150 ng/mL on days 1, 3 and 7. The levels of carboxyprimaquine in whole blood samples ranged from 87-234 ng/mL, 96-252 ng/mL and 74-448 ng/mL on days 1, 3 and 7. These data provide a reliable estimation of exposure of the infecting parasite to primaquine. Based on the regional pattern of relapse, the estimated blood levels of primaquine can be considered effective against hypnozoites of the local circulating strains of P. vivax.
Documentos Relacionados
- Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon
- Factors associated with non-adherence to the treatment of vivax malaria in a rural community from the Brazilian Amazon Basin
- Asymptomatic infection with Plasmodium falciparum and Plasmodium vivax in the Brazilian Amazon Basin: to treat or not to treat?
- Quinine levels in patients with uncomplicated falciparum malaria in the Amazon region of Brazil
- Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon